Reuters UK Top

Air defences down 12 Ukrainian drones in the space of an hour in southern region, governor says

(Reuters) – Russian air defence units intercepted 12 Ukrainian drones in the space of an hour late on Friday over southern Russia’s border region of Bryansk, the regional governor said. “Thanks to our valiant defenders, all airborne targets were intercepted and destroyed,” Governor Alexander Bogomaz wrote on the Telegram messaging app. There were no casualties …

Air defences down 12 Ukrainian drones in the space of an hour in southern region, governor says Read More »

One killed, nine injured in blast at Russian gas field, says Russia’s technical watchdog

MOSCOW (Reuters) -A blast at the East Urengoy gas condensate field in the Yamal-Nenets region in Russia’s Arctic has killed one worker and injured nine others and its cause is being investigated, Russian technical watchdog Rostechnadzor said on Friday. The facility is operated by a company controlled by Russian state-owned Rosneft. The explosion occurred while …

One killed, nine injured in blast at Russian gas field, says Russia’s technical watchdog Read More »

France’s Macron declares Paris 2024 Olympics open

PARIS (Reuters) – French President Emmanuel Macron declared the 2024 Paris Olympic Games open on Friday during a rain-soaked ceremony in the French capital. (Reporting by Tassilo Hummel; Editing by Leigh Thomas)

EU clears $2.2 billion Dutch state aid for medical isotopes for cancer treatment

By Foo Yun Chee BRUSSELS (Reuters) – The Netherlands on Friday secured EU approval for 2 billion euros ($2.2 billion) of state aid to build a nuclear reactor to produce medical isotopes for cancer treatment. The European Commission, which acts as the EU competition enforcer said the support helps ensure the security of supply of …

EU clears $2.2 billion Dutch state aid for medical isotopes for cancer treatment Read More »

Alzheimer’s drug from Eisai and Biogen rejected in Europe

By Manas Mishra and Puyaan Singh (Reuters) -The European Union’s drugs regulator has rejected Eisai and Biogen’s Leqembi treatment for early Alzheimer’s disease, saying the risk of serious brain swelling did not outweigh its small impact on slowing cognitive decline. The decision is a blow to the companies as the drug faces slow take-up in …

Alzheimer’s drug from Eisai and Biogen rejected in Europe Read More »

Close Bitnami banner
Bitnami